Current disease status-First occurrence of the cancer - Page 25 of 59 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

Combining chemotherapy and hormone therapy early for metastatic prostate cancer

Combining chemotherapy and hormone therapy early for metastatic prostate cancer

Posted by on Jun 27, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the safety and effectiveness of androgen deprivation therapy (ADT) plus docetaxel (Taxotere) compared to ADT alone for metastatic prostate cancer. Researchers reported increased progression-free survival and overall survival when ADT was combined with docetaxel. Some background ADT is a type of hormone therapy...

Read More

Now less invasive: Imaging-guided radiation techniques for prostate cancer

Posted by on Jun 20, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared the safety and effectiveness of two forms of imaging-guided radiation techniques for prostate cancer. Researchers reported more favorable outcomes with intensity modulated radiation therapy (IMRT) than with 3-dimensional conformal radiation therapy (3DCRT). Some background Radiation therapy is a common treatment...

Read More

Searching for overweight men with low-risk prostate cancer undergoing active surveillance

Posted by on Jun 13, 2016 in Prostate cancer | 0 comments

In a nutshell This phase 3 trial aims to evaluate the benefit of a diet and exercise program in overweight men with low-risk prostate cancer. The main outcome to be investigated is a change in blood sugar metabolism in prostate cancer cells. The trial is recruiting in Seattle (Washington), USA. The details Low-risk prostate cancer is often managed...

Read More

Eribulin – a treatment for metastatic breast cancer

Eribulin – a treatment for metastatic breast cancer

Posted by on Jun 13, 2016 in Breast cancer | 0 comments

In a nutshell This study investigated the safety and effectiveness of the drug eribulin (Halaven) for the treatment of patients with metastatic breast cancer and resistance to taxane therapies. The study concluded that eribulin was effective and well tolerated in patients with metastatic breast cancer. Some background Taxanes are a type of...

Read More

Low-risk prostate cancer management – an overview

Posted by on Jun 6, 2016 in Prostate cancer | 0 comments

In a nutshell This review examined recent findings and recommendations for the management of low-risk localized prostate cancer. Authors concluded that watchful waiting and active surveillance are suitable options for most men with low-risk prostate cancer. Some background Due to advances in the early detection of prostate cancer, many prostate...

Read More

Depression and capacity to manage problems associated with recovery in patients with colorectal cancer

Depression and capacity to manage problems associated with recovery in patients with colorectal cancer

Posted by on May 30, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the predictors of recovery of patients with colorectal cancer two years after surgery. Researchers reported that depression and capacity to manage problems before surgery are associated with health and well-being in recovery two years after surgery.  Some background The support a cancer patients receives...

Read More